MD, PhD. Jose Ibeas

Doctor of Medicine (Ph.D.) Master’s Degree in Evidence-based Medicine. Postgraduate in Big Data Processing and Artificial Intelligence for Life Sciences. Currently Consultant at the Nephrology Department; Director of the Clinical, Interventional and Computational Nephrology Group of the Research and Innovation Institute of the Parc Taulí University Hospital (www.tauli.cat/cicn). He has a great deal of experience in Chronic Kidney Disease and Vascular Access in the field of care, teaching and research, with more than 500 communications and lectures at national and international congresses and several national and international publications, the direction of Doctoral Theses; and recipient of 13 awards. Member of the Clinical Research Ethics Committee of the Hospital Universitari Parc Taulí. He has been Director of numerous national and international courses and symposia, in particular, the Co-chair of the 9th Congress of the Vascular Access Society (2015) and Chair of the First and Second GEMAV Meetings (Spanish Multidisciplinary Group on Vascular Access), 2019 and 2020 (www.gemav-eventos.com). Organizing Committee of the 12^th Congress of the Vascular Access Society, April 2021 (www.vas2021.org) and 3^rd GEMAV meeting

He is the Secretary of the Vascular Access Working Group that belongs to the Spanish Society of Nephrology. Member of the Vascular Access Working Group of the Catalan Society of Nephrology. Member of the Interventional Nephrology working group of the Spanish Society of Nephrology. Vice-President of the Spanish Multidisciplinary Group on Vascular Access (GEMAV) [www.gemav.org]. Past-President of the Vascular Access Society (VAS) [www.vascularaccesssociety.com]. Past-member of the council of the International Committee of the American Society of Diagnostic and Interventional Nephrology, Chair of the Work Group for the Clinical Guidelines on Vascular Access of the GEMAV, member of the European Vascular Access Guidelines Group of the ERA-EDTA and member of the Clinical Practice Guide on Chronic Renal Disease Group of the Spanish National Health System. Member of the Artificial Intelligence working group of the Spanish Society of Nephrology. Director of the Master in Artificial Intelligence and Big Data in Health of Parc Taulí University Hospital & School of Engineering of the Autonomous University of Barcelona (www.tauli.cat/ias).

The main areas of current interest focus on the study of biomarkers in advanced renal failure and hemodialysis, emphasizing those related to inflammation, immunity, early biomarkers of infection, bioimpedance and in particular to vascular access. It is in the vascular access field, where he had spent most of the activity last years around interventional nephrology; highlighting the systems of monitoring and treatment of diseases related to both the catheter and the native and prosthetic vascular access. And, particularly, the introduction of Doppler ultrasound in the dialysis unit by the nephrologist and nurses in the protocols of vascular access planning and monitoring of multidisciplinary basis. Respect basic/translational investigations, the main area of interest are intima-media hyperplasia, inflammation biomarkers, infection, ultrasound surveillance and artificial intelligence. Promoter of NephroCloud software for vascular access management (www.nephrocloud.net) and Anais for Anatomical Interventional Simulation Models (www.anaismedical.com) for training.

Las principales áreas de interés actual del Dr. Ibeas se centran en el estudio de bio

marcadores en la insuficiencia renal avanzada y hemodiálisis, destacando los relacionados con inflamación, inmunidad, biomarcadores tempranos de infección, bioimpedancia y en particular al acceso vascular.

Es en el campo de los accesos vasculares donde el doctor Ibeas ha centrado la mayor parte de la actividad de los últimos años, más concrétamente en torno a la nefrología intervencionista; destacando los sistemas de seguimiento y tratamiento de enfermedades relacionadas tanto con el catéter como con el nativo y protésico acceso vascular. Y, en particular, la introducción de la ecografía Doppler en la unidad de diálisis por parte del nefrólogo y enfermeras en los protocolos de planificación y seguimiento del acceso vascular de base multidisciplinar. Respecto a las investigaciones básicas / traslacionales, las principales áreas de interés son la hiperplasia íntimamedia, biomarcadores de inflamación, infección, vigilancia ecográfica e inteligencia artificial. Promotor además del software NephroCloud para la gestión del acceso vascular (www.nephrocloud.net) y Anais para modelos de simulación anatómica intervencionista (www.anaismedical.com) para formación.

Nefrólogo en Hospital Universitario Parc Taulí / Responsable de Grupo de Nefrología Clínica Intervencionista y Computacional del Insitut de Investigació e Innovació Parc Taulí / Ex Presidente de la Vascular Access Society / Vicepresidente de GEMAV / Secretario del grupo de accesos vasculares de la Sociedad Española de Nefrología / Vocal del grupo de nefrología intervencionista de la Sociedad Española de Nefrología.